Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report

This is a case of a 60‐year‐old man living with HIV who presented with advanced cutaneous squamous cell carcinoma. After workup, medical and surgical treatment, and disease recurrence, he achieved a complete response with no unexpected toxicities after immunotherapy with cemiplimab.

Detalles Bibliográficos
Autores principales: Alloghbi, Abdurahman, Ninia, James, Alshare, Bayan, Hotaling, Jeffrey, Raza, Syed, Sukari, Ammar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673230/
https://www.ncbi.nlm.nih.gov/pubmed/34950481
http://dx.doi.org/10.1002/ccr3.5228
_version_ 1784615446763274240
author Alloghbi, Abdurahman
Ninia, James
Alshare, Bayan
Hotaling, Jeffrey
Raza, Syed
Sukari, Ammar
author_facet Alloghbi, Abdurahman
Ninia, James
Alshare, Bayan
Hotaling, Jeffrey
Raza, Syed
Sukari, Ammar
author_sort Alloghbi, Abdurahman
collection PubMed
description This is a case of a 60‐year‐old man living with HIV who presented with advanced cutaneous squamous cell carcinoma. After workup, medical and surgical treatment, and disease recurrence, he achieved a complete response with no unexpected toxicities after immunotherapy with cemiplimab.
format Online
Article
Text
id pubmed-8673230
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86732302021-12-22 Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report Alloghbi, Abdurahman Ninia, James Alshare, Bayan Hotaling, Jeffrey Raza, Syed Sukari, Ammar Clin Case Rep Case Report This is a case of a 60‐year‐old man living with HIV who presented with advanced cutaneous squamous cell carcinoma. After workup, medical and surgical treatment, and disease recurrence, he achieved a complete response with no unexpected toxicities after immunotherapy with cemiplimab. John Wiley and Sons Inc. 2021-12-15 /pmc/articles/PMC8673230/ /pubmed/34950481 http://dx.doi.org/10.1002/ccr3.5228 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Alloghbi, Abdurahman
Ninia, James
Alshare, Bayan
Hotaling, Jeffrey
Raza, Syed
Sukari, Ammar
Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
title Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
title_full Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
title_fullStr Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
title_full_unstemmed Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
title_short Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
title_sort anti‐pd‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in hiv patient: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673230/
https://www.ncbi.nlm.nih.gov/pubmed/34950481
http://dx.doi.org/10.1002/ccr3.5228
work_keys_str_mv AT alloghbiabdurahman antipd1therapyusingcemiplimabforadvancedcutaneoussquamouscellcarcinomainhivpatientacasereport
AT niniajames antipd1therapyusingcemiplimabforadvancedcutaneoussquamouscellcarcinomainhivpatientacasereport
AT alsharebayan antipd1therapyusingcemiplimabforadvancedcutaneoussquamouscellcarcinomainhivpatientacasereport
AT hotalingjeffrey antipd1therapyusingcemiplimabforadvancedcutaneoussquamouscellcarcinomainhivpatientacasereport
AT razasyed antipd1therapyusingcemiplimabforadvancedcutaneoussquamouscellcarcinomainhivpatientacasereport
AT sukariammar antipd1therapyusingcemiplimabforadvancedcutaneoussquamouscellcarcinomainhivpatientacasereport

Ejemplares similares